mygluco.com "now it's easier to take care of yourself"

Over 84% of the type 2 diabetes trial participants reduced their blood glucose levels as measured by a highly accurate hemoglobin A1c laboratory test by an average of 1.1 points; a significant improvement in blood sugar control.

As a speaker at ADA Scientific in the symposium entitled, "Beyond Health Care Practitioners – Diabetes Health Care Extenders", McMahon presented the data showing that twenty-six adult patients with type 2 diabetes participated in this 12 month study.

Following enrollment and establishment of the patient's profile, patient participants were given Diabetech's market leading GlucoMON® wireless glucose meter for automated and accurate blood glucose data
collection, automated GlucoDYNAMIX™ blood glucose logbooks from their online personal health record (PHR), QuickTips™ lifestyle and diabetes educational messages, HomeCheck™ hematology screening and
A1c laboratory tests at enrollment and every 90 days thereafter, activity guides and more. Minimal human intervention from program staff and practitioners in this trial also demonstrates the efficiencies gained
using automated technology instead of weekly phone calls from highly skilled professionals who are also in limited supply.
Diabetech® Presents Type 2 Diabetes
Clinical Trial Results at ADA Scientific Sessions (Full Release Pdf)